Chemoinformaics analysis of trans-Propenyl propyl disulfide
| Molecular Weight | 148.296 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.2 | nRig | 1 |
| Exact Molecular Weight | 148.038 | nRing | 0 |
| Solubility: LogS | -3.473 | nHRing | 0 |
| Solubility: LogP | 3.203 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 23.8215 |
| nHD | 0 | BPOL | 14.4985 |
| QED | 0.443 |
| Synth | 3.844 |
| Natural Product Likeliness | 2.162 |
| NR-PPAR-gamma | 0.151 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.244 |
| MDCK | 0.0000208 |
| BBB | 0.874 |
| PPB | 0.926898 |
| VDSS | 3.002 |
| FU | 0.0665524 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.9 |
| CYP2c19-inh | 0.888 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.265 |
| CYP2c9-sub | 0.877 |
| CYP2d6-inh | 0.483 |
| CYP2d6-sub | 0.862 |
| CYP3a4-inh | 0.077 |
| CYP3a4-sub | 0.226 |
| CL | 12.766 |
| T12 | 0.346 |
| hERG | 0.006 |
| Ames | 0.369 |
| ROA | 0.064 |
| SkinSen | 0.952 |
| Carcinogencity | 0.125 |
| EI | 0.995 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.042 |
| Antiviral | No |
| Prediction | 0.950833 |